Egyszerű nézet

dc.contributor.author De Berardis D
dc.contributor.author Fornaro M
dc.contributor.author Orsolini L
dc.contributor.author Valchera A
dc.contributor.author Carano A
dc.contributor.author Vellante F
dc.contributor.author Perna G
dc.contributor.author Serafini G
dc.contributor.author Gonda Xénia
dc.contributor.author Pompili M
dc.contributor.author Martinotti G
dc.contributor.author Di Giannantonio M
dc.date.accessioned 2018-05-02T17:27:36Z
dc.date.available 2018-05-02T17:27:36Z
dc.date.issued 2017
dc.identifier.citation pagination=148, 6 pages journalVolume=8; journalTitle=FRONTIERS IN PSYCHIATRY;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/4620
dc.identifier.uri doi:10.3389/fpsyt.2017.00148
dc.description.abstract It is well known that alexithymic individuals may show significantly higher levels of anxiety, depression, and psychological suffering than non-alexithymics. There is an increasing evidence that alexithymia may be considered a risk factor for suicide, even simply increasing the risk of development of depressive symptoms or per se. Therefore, the purpose of this narrative mini-review was to elucidate a possible relationship between alexithymia and suicide risk. The majority of reviewed studies pointed out a relationship between alexithymia and an increased suicide risk. In several studies, this relationship was mediated by depressive symptoms. In conclusion, the importance of alexithymia screening in everyday clinical practice and the evaluation of clinical correlates of alexithymic traits should be integral parts of all disease management programs and, especially, of suicide prevention plans and interventions. However, limitations of studies are discussed and must be considered.
dc.relation.ispartof urn:issn:1664-0640
dc.title Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review.
dc.type Journal Article
dc.date.updated 2018-01-08T09:16:00Z
dc.language.rfc3066 en
dc.identifier.mtmt 3285898
dc.identifier.pubmed 28855878
dc.contributor.department SE/GYTK/GYHATAS/MTA-SE Neuropszichofarmakológiai és Neurokémiai Kutatócsoport
dc.contributor.department SE/GYTK/Gyógyszerhatástani Intézet
dc.contributor.department SE/AOK/K/Pszichiátriai és Pszichoterápiás Klinika
dc.contributor.department SE/GYTK/GYHATAS/MTA-SE Neuropszichofarmakológiai és Neurokémiai Kutatócsoport
dc.contributor.institution Semmelweis Egyetem


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet